shh.sePublications
EnglishSvenskaNorsk
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Can breast cancer register data on recommended adjuvant treatment be used as a proxy for actually given treatment?
Sophiahemmet University.ORCID iD: 0000-0002-3457-4737
Show others and affiliations
2016 (English)In: European Journal of Oncology Nursing, ISSN 1462-3889, E-ISSN 1532-2122, Vol. 22, p. 1-7Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2016. Vol. 22, p. 1-7
Keywords [en]
Breast cancer, Register data, Recommended adjuvant treatment, Radiotherapy, Chemotherapy, Endocrine therapy
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:shh:diva-2151DOI: 10.1016/j.ejon.2016.02.010OAI: oai:DiVA.org:shh-2151DiVA, id: diva2:913739
Available from: 2016-03-22 Created: 2016-03-22 Last updated: 2020-06-02Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records

Wennman-Larsen, Agneta

Search in DiVA

By author/editor
Wennman-Larsen, Agneta
By organisation
Sophiahemmet University
In the same journal
European Journal of Oncology Nursing
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 331 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
v. 2.45.0
|
WCAG
|
Library